![](/img/cover-not-exists.png)
Efficacy and safety of grepafloxacin 600 mg daily for 10 days in patients with community-acquired pneumonia
Stuart Topkis, Herbert Swarz, Sally A. Breisch, Allan N. MaroliVolume:
19
Year:
1997
Language:
english
DOI:
10.1016/s0149-2918(97)80050-1
File:
PDF, 1003 KB
english, 1997